Yamamoto, Kana
Kuriu, Toshihiko http://orcid.org/0000-0001-9125-891X
Matsumura, Kensuke
Nagayasu, Kazuki
Tsurusaki, Yoshinori
Miyake, Noriko
Yamamori, Hidenaga
Yasuda, Yuka
Fujimoto, Michiko
Fujiwara, Mikiya
Baba, Masayuki
Kitagawa, Kohei
Takemoto, Tomoya
Gotoda-Nishimura, Nanaka
Takada, Tomohiro
Seiriki, Kaoru
Hayata-Takano, Atsuko
Kasai, Atsushi http://orcid.org/0000-0002-1612-3078
Ago, Yukio http://orcid.org/0000-0001-7562-4000
Kida, Satoshi http://orcid.org/0000-0002-8038-9583
Takuma, Kazuhiro
Ono, Fumihito http://orcid.org/0000-0001-7532-5262
Matsumoto, Naomichi http://orcid.org/0000-0001-9846-6500
Hashimoto, Ryota
Hashimoto, Hitoshi http://orcid.org/0000-0001-6548-4016
Nakazawa, Takanobu http://orcid.org/0000-0003-4863-1277
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (JP18H02574, JP20K21464, JP18H05416, JP19H05218, JP20K07057, JP20H03556, JP20H03391, JP20K21479, JP19H05217, JP20H03392, JP17H03989, JP20H00492, JP21K19335, JP18H05416)
Japan Agency for Medical Research and Development (JP20gm1310003, JP20dm0107122, JP20dm0207061, JP20am0101084)
Takeda Science Foundation (ND, ND)
Asahi Glass Foundation (ND)
Naito Foundation (ND)
Article History
Received: 21 August 2021
Revised: 5 October 2021
Accepted: 12 October 2021
First Online: 25 October 2021
COMPETING INTERESTS
: K.Y., K.M., and M. Fujiwara are employed by Chugai Pharmaceutical Co., Ltd, Shionogi & Co., Ltd, and Nippon Shinyaku Co., Ltd, respectively. The remaining authors declare no competing interests.